Stribild Access
These highlights do not include all the information needed to use STRIBILD safely and effectively. See full prescribing information for STRIBILD. STRIBILD™ (elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate) tablets, for oral use GILEAD ACCESS PROGRAM Initial U.S. Approval: 2012
d52f7766-068f-4a2f-b748-356ff60450f7
HUMAN PRESCRIPTION DRUG LABEL
Mar 29, 2021
Gilead Sciences, Inc.
DUNS: 185049848
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate
Product Details
FDA regulatory identification and product classification information